Role of Toll-Like Receptors in Respiratory Diseases;Papel de los receptores toll-like en las enfermedades respiratorias

Archivos de Bronconeumologia

Volumn 46, Issue 3, 2010, Pages 135-142

  Crespo Lessmann, Astrid ^a   Juárez Rubio, Cándido ^a   Plaza Moral, Vicente ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Acquired immunity; Asthma; COPD; Innate immunity; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ALLERGIC DISEASE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; HUMAN; IMMUNOPATHOGENESIS; INFECTION; INNATE IMMUNITY; PROTEIN ANALYSIS; PROTEIN FUNCTION; RESPIRATORY TRACT DISEASE; SHORT SURVEY;

EID: 76749096225     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(10)70034-3     Document Type: Review

References (105)

1. Arancibia S., Beltrán C., Aguirre I., Silva P., Peralta A., Malinarich F., et al. Toll-like receptor are key participants in innate immune responses [revisión]. Biol Res 40 (2007) 97-112
2. Xu D., Liu H., and Komai-Koma M. Direct and indirect role of toll-like receptor in T cell mediated immunity [revisión]. Cell Mol Inmunol 1 (2004) 239-246
3. Redecke V., Häcker H., Datta S., Fermin A., Pitha P., Broide D., et al. Cutting edge: activation of toll-like receptor 2 induces a Th2 immune respose and promote experimental asthma. J Immunol 172 (2004) 2739-2743
4. Duez C., Gosset P., and Tonnel A. Dendritic cells and toll-like receptors in allergy and asthma [revisión]. Eur J Dermatol 16 (2006) 12-16
5. Gon Y. Toll-Like receptors and airway inflammation [revisión]. Allergol Int 57 (2008) 33-37
6. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., and Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
7. Medzhitov R., Preston-Hurlburt P., and Janeway C.A. A human homologue of the Drosophila toll protein signals activation of adaptative immunity. Nature 388 (1997) 394-397
8. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
9. Creagh E.M., and O'Neill L.A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 27 (2006) 352-357
10. Akira S. Mammalian Toll-like receptors. Curr Opin Immunol 15 (2003) 5-11
11. Yamamoto M., Takeda K., and Akira S. TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol 40 (2004) 861-868
12. Kopp E.B., and Medzhitov R. The toll-receptor family and control of innate immunity. Curr Opin Immunol 11 (1999) 13-18
13. Gay N.J., and Keith F.J. Drosophila toll and IL-1 receptor. Nature 351 (1991) 355-356
14. Fritz J.H., and Girardon D.E. How toll-like receptors and Nod-like receptors contribute to innate immunity in mammals. J Endotoxin Res 11 (2005) 390-394
15. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu Rev Immunol 27 (2006) 352-357
16. Eiland C.W., Knapp S., Florquin S., De Vos A.F., Takeda K., Akira S., et al. Non-mannose-capped lipoarabinomannan induces ling inflammation via toll-like receptor 2. Am J Respir Crit Care Med 170 (2004) 1367-1374
17. Sa Silva J., Soldau K., Cristen U., Tobias P.S., and Ulevith R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex, transfer from CD14 to TLR4 and MD-2. J Biol Chem 276 (2001) 21129-21135
18. Smith K.D., Andersen E., Hayashi F., Cookson B.T., and Aderem A. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 4 (2003) 1247-1253
19. Jefferies C.A., and Fitzgerald K.A. Interferon gene regulation: not all roads lead to Tolls. Trends Mol Med 11 (2005) 403-411
20. Bowie A.G., and Haga I.R. The role of toll-like receptors in the host response to viruses. Mol Immunol 42 (2005) 859-867
21. Boehme K.W., and Compton T. Innate sensing of viruses by toll-like receptors. J Virol 78 (2004) 7867-7873
22. Kawai T., Sato S., Ishii K.J., Coban C., Hemmi H., Yamamoto M., et al. Interferon-alpha induction through toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5 (2004) 1061-1068
23. Moynagh P.N. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol 26 (2005) 469-476
24. Du X., Poltorak A., Wei Y., and Beutler B. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 11 (2000) 362-371
25. Chuang T.H., and Ulevitch R.J. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 11 (2000) 372-378
26. Rock F.L., Hardiman G., Timans J.C., Kastelein R.A., and Bazan J.F. A family of human receptors structurally related to Drosophila toll. Proc Natl Acad Sci USA 95 (1998) 588-593
27. Zarember K.A., and Godowski P.J. Tissue expression of human toll-like receptors and differential regulation of toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168 (2002) 554-561 [fe de errores en: J Immunol. 2002;169:1136.]
28. Ochoa M.T., Legaspi A.J., Hatziris Z., Godowski P.J., Modlin R.L., and Sieling P.A. Distribution of toll-like receptor 1 and toll-like receptor 2 in human lymphoid tissue. Immunology 108 (2003) 10-15
29. Muzio M., Bosisio D., Polentarutti N., D'Amico G., Stoppacciaro A., Mancinelli R., et al. Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164 (2000) 5998-6004
30. Hornung V., Rothenfusser S., Britsch S., Krug A., Jahrsdörfer B., Giese T., et al. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168 (2002) 4531-4537
31. Compton T., Kurt-Jones E.A., Boehme K.W., Belko J., Latz E., Golenbock D.T., et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2. J Virol 77 (2003) 4588-4596
32. Muroi M., Ohnishi T., and Tanamoto K. Regions of the mouse CD14 molecule required for toll-like receptor 2- and 4-mediated activation of NF-kappa B. J Biol Chem 277 (2002) 42372-42379
33. Rehli M. Of mice and men: species variations of toll-like receptor expression. Trends Immunol 23 (2002) 375-378
34. Zhang H., Tay P.N., Cao W., Li W., and Lu J. Integrin-nucleated toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling. FEBS Lett 532 (2002) 171-176
35. Takeuchi O., Kawai T., Sanjo H., Copeland N.G., Gilbert D.J., Jenkins N.A., et al. TLR6: a novel member of an expanding toll-like receptor family. Gene 231 (1999) 59-65
36. Heine H., and Lien E. Toll-like receptors and their function in innate and adaptive immunity. Int Arch Allergy Immunol 130 (2003) 180-192
37. Dunne A., and O'Neill L.A. The interleukin-1 receptor/toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 171 (2003) re3
38. Chuang T.H., and Ulevitch R.J. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur Cytokine Netw 11 (2000) 372-378
39. Skrepnek G.H., and Skrepnek S.V. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 10 (2004) S129-S138
40. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
41. Hoffjan S., and Ober C. Present status on the genetic studies of asthma. Curr Opin Immunol 14 (2002) 709-717
42. Castillo J.A., and Mullol J. Rhinitis and asthma comorbidity in Spain: the RINAIR study. Arch Bronconeumol 44 (2008) 597-603
43. Bowcock A.M., and Cookson W.O. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 13 Spec No 1 (2004) R43-R55
44. Molfino N.A. Genetics of COPD. Chest 125 (2004) 1929-1940
45. Arnedo-Pena A., García-Marcos L., Carvajal I., Busquets R., Morales M., Miner C., et al. Air pollution and recent symptoms of asthma, allergic rhinitis, and atopic eczema in schoolchildren aged between 6 and 7 years. Arch Bronconeumol 45 (2009) 224-229
46. Martínez F.D. The coming-of-age of the hygiene hypothesis. Respir Res 2 (2001) 129-132
47. Weiss S.T. Eat dirt - the hygiene hypothesis and allergic diseases. N Engl J Med 347 (2002) 930-931
48. Elías M.T., Sánchez R., Cayuela A., Álvarez F.J., Romero J.A., García A., et al. Risk factors for bronchial asthma in patients with rhinitis. Arch Bronconeumol 37 (2001) 429-434
49. Prieto L., and Morales C. Allergic rhinitis and asthma as probable clinical manifestations of the same process. Arch Bronconeumol 34 (1998) 277-280
50. Leckie M.J., Ten Brinke A., Khan J., Diamant Z., O'Connor B.J., Walls C.M., et al. Effect of an interleukin-5 blocking monoclonal antibody on eosinophiles, airway hyperresponsiveness and the response to allergen in patients with asthma. Lancet 356 (2000) 2144-2148
51. Bryan S.A., O'Connor B.J., Matti S., Leckie M.J., Kanabar V., Khan J., et al. Effects of recombinant human interleukin-12 on eosinophiles, airway hyper-responsiveness, and the late asthmatic response. Lancet 356 (2000) 2149-2153
52. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Resp J 22 (2003) 470-477
53. Pizzichini M.M., Pizzichini E., Efthimiadis A., Chauhan A.J., Johnston S.L., Hussack P., et al. Asthma and natural cold. Inflammatory indices in induced sputum: a feasibility study. Am J Resp Crit Care Med 158 (1998) 1178-1184
54. Sur S., Crotty T.B., Kephart G.M., Hyma B.A., Colby T.V., Reed C.E., et al. Sudden-onset fatal asthma. A distinct entity with few eosinophiles and relatively more neutrophils in the airway submucosa. Am Rev Respir Dis 148 (1993) 713-719
55. Álvarez F.J., Valenzuela F., Rodríguez J.A., Sánchez R., Tabernero E., and Castillo J. Blood levels of eosinophil cationic protein in patients with allergic rhinitis. Evolution after treatment with corticoids. Arch Bronconeumol 33 (1997) 6-11
56. Álvarez F.J., Rodríguez J.A., Valenzuela F., Capote F., Sánchez R., and Castillo J. Inflammation mediators (eosinophilic cationic protein, ECP) in a normal population and in patients with bronchial asthma or allergic rhinitis. Arch Bronconeumol 31 (1995) 280-286
57. Gibson P.G., Simpson J.L., and Saltos N. Heterogeneity of airway inflammation in persistent asthma. Chest 119 (2001) 1329-1336
58. Pavord I.D., Brightling C.E., Woltmann G., and Wardlaw A.J. Non-eosinophilic corticosteroid unresponsive asthma. Lancet 353 (1999) 2213-2214
59. Turner M.O., Hussack P., Sears M.R., Dolovich J., and Hargreave F.E. Exacerbations of asthma without sputum eosinophilia. Thorax 50 (1995) 1057-1061
60. Anees W., Huggins V., Pavord I.D., Robertson A.S., and Burge P.S. Occupational asthma due to low molecular weight agents:eosinophilic and non-eosinophilic variants. Thorax 57 (2002) 231-236
61. Wenzel S.E., Schwartz L.B., Langmack E.L., Halliday J.L., Trudeau J.B., Gibbs R.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 160 (1999) 1001-1008
62. Helenius I., Lumme A., and Haahtela T. Asthma, airway inflammation and treatment in elite athletes. Sport Med 35 (2005) 565-574
63. Lumme A., Haahtela T., Ounap J., Rytilä P., Obase Y., Helenius M., et al. Airway inflammation, bronchial hyperresponsiveness and asthma in elite ice hockey players. Eur Respir J 22 (2003) 113-117
64. Wenzel S.E., Balzar S., Cundall M., and Chu H.W. Subepithelial basement membrane immunoreactivity for matrix, metalloproteinase 9: association with asthma severity, neutrophilic inflammation and wound repair. J Allergy Clin Immunol 111 (2003) 1345-1352
65. Cundall M., Sun Y., Miranda C., Trudeau J.B., Barnes S., and Wenzel S.E. Neutrophil-derived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy Clin Immunol 112 (2003) 1064-1071
66. Simpson J.L., Scott R., Boyle M.J., and Gibson P.G. Inflammatory subtypes in asthma: assessment and identification using sputum. Respirology 11 (2006) 54-61
67. Douwes J., Gibson P., Pekkanen J., and Pearce N. Non-eosinophilic asthma: importance and posible mechanisms. Thorax 47 (2002) 643-648
68. Janeway C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
69. Simpson J., Grissell T., Douwes J., Scott R., Boyle M., and Gibson P. Innate immune activation in neutrophilic asthma and bronquiectasis. Thorax 62 (2007) 211-218
70. Tan W.C. Viruses in asthma exacerbations. Curr Opin Pulm Med 11 (2005) 21-26
71. Kline J.N., and Krieg A.M. Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy. Drug News Perspect 21 (2008) 434-439
72. Fonseca D.E., and Kline J.N. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Adv Frug Deliv Rev 61 (2009) 256-262
73. Kline J.N. Inmunotherapy of asthma using CpG oligodeoxynucleotides. Immunol Res 39 (2007) 279-286
74. Peter Fritsch. Dermatologie Venerologie: Grundlagen. Klinik. Atlas. Berlin: Springer; 2004.
75. Du Q., Zhou L.F., Chen Z., Gu X.Y., Huang M., and Yin K.S. Imiquimod, a toll like receptor 7 ligand, inhibits airway remodeling in a murine model of chronic asthma. Clin Exp Pharmacol Physiol 36 (2009) 43-48
76. Davila S., Hibberd M., Hari R., Wong H., Sahiratmadja E., Bonnard C., et al. Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet 4 (2008) e1000218
77. Imai Y., Kuba K., Neely G., Yaghubian-Malhami R., PerKmann T., Loo G., et al. Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133 (2008) 235-249
78. Murray L., Knight D., McAlonan L., Argentieri R., Joshi A., Shaheen F., et al. Deleterious role of TLR3 during hyperoxia-induced acute lung injury. Am J Respir Crit Care Med 178 (2008) 1227-1237
79. Wong J.P., Christopher M.F., Viswanathan S., Karpoff N., Dai X., Das D., et al. Activation of toll-like receptor signaling pathway for protection against influenza virus infection. Vaccine 27 (2009) 3481-3483
80. Sarir H., Henricks P.A., Van Houwelingen A.H., Nijkamp F.P., and Folkerts G. Cells, mediators and toll-like receptors in COPD. Eur J Pharmacol 585 (2008) 346-353
81. Rennard S.I., and Vestbo J. COPD: the dangerous underestimate of 15%. Lancet 367 (2006) 1216-1219
82. Devereux G. ABC of chronic obstructive pulmonary disease. Definition, epidemiology, and risk factors. BMJ 332 (2006) 1142-1144
83. Martorana P.A., Brand T., Gardi C., Van Even P., De Santi M.M., Calzoni P., et al. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency. Lab Invest 68 (1993) 233-241
84. Hautamaki R.D., Kobayashi D.K., Senior R.M., and Shapiro S.D. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277 (1997) 2002-2004
85. Kuro-o M., Matsumura Y., Aizawa H., Kawaguchi H., Suga T., Utsugi T., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390 (1997) 45-51
86. Wert S.E., Yoshida M., LeVine A.M., Ikegami M., Jones T., Ross G.F., et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 97 (2000) 5972-5977
87. Smith C.A., and Harrison D.J. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350 (1997) 630-633
88. Rangasamy T., Cho C.Y., Thimmulappa R.K., Zhen L., Srisuma S.S., Kensler T.W., et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest 114 (2004) 1248-1259
89. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 50-60
90. Zhang X., Shan P., Jiang G., Cohn L., and Lee P. Research article. Toll-like receptor 4 deficiency causes pulmonary emphysema. J Clin Invest 116 (2006) 3050-3059
91. Fuchs B., and Braun A. Modulation of asthma and allergy by addressing toll-like receptor 2. J Occup Med Toxicol 3 Suppl I (2008) S5
92. Pons J., Sauleda J., Regueiro V., Santos C., López M., Ferrer J., et al. Expression of toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res 7 (2006) 64
93. Paul-Clark M.J., McMaster S.K., Sorrentino R., Sriskandan S., Bailey L.K., Moreno L., et al. Toll-like receptor 2 is essential for the sensing of oxidants during inflammation. Am J Respir Crit Care Med 179 (2009) 299-306
94. Droemann D., Goldmann T., Tiedje T., Zabel P., Dalhoff K., and Schaaf B. Toll-like receptor 2 expression is decreased on alveolar macrophages in cigarette smokers and COPD patients. Respir Res 6 (2005) 68
95. Zhou M., Wan H.Y., Huang S.G., Li B., and Li M. Expression of toll-like receptor 4 in human alveolar epithelial cells and its role in cellular inflammation. Zhoghua Y Xue Za Zhi 88 (2008) 2112-2116
96. Pons J., Sauleda J., Regueiro V., Santos C., López M., Ferrer J., et al. Expression of toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease. Respir Res 7 (2006) 64
97. Doz E., Noulin N., Boichot E., Guénon I., Fick L., Le Bert M., et al. Cigarette smoke-induced pulmonary inflammation is TLR4/MyD88 and IL-1R1/MyD88 signaling dependent. J Immunol 180 (2008) 1169-1178
98. Noakers P.S., Hale J., Thomas R., Lane C., Devadason S.G., and Prescott S.L. Maternal smoking is associated with impaired neonatal toll-like receptor mediated immune responses. Eur Respir J 28 (2006) 675-677
99. Hoffjan S., Stemmler S., Parwez Q., Petrasch-Parwez E., Umut A., Rohde G., et al. Evaluation of the toll-like receptor 6 Ser249Pro polymorphism in patients with asthma, atopic dermatitis and chronic obstructive pulmonary disease. BMC Med Genet 6 (2005) 34
100. Meyers D.A., Larj M.J., and Lange L. Genetics of asthma and COPD. Similar results for different phenotypes. Chest 126 (2004) 105S-110S
101. Homma T., Kato A., Hashimoto N., Batchelor J., Yoshikawa M., Imai S., et al. Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. Am J Respir Cell Mol Biol 31 (2004) 463-469
102. Blohmake C.J., Victor R.E., Hirschfeld A.F., Elias I.M., Hancock D.G., Lane C.R., et al. Innate immunity mediated by TLR5 as a novel antiinflamatory target for cystic fibrosis lung disease. J Immunol 180 (2008) 7764-7773
103. Koller B., Kappler M., Latzin P., Gaggar A., Schreiner M., Takyar S., et al. TLR expression on neutrophils at the pulmonary site of infection: TLR1/TLR2-mediated up-regulation of TLR5 expression in cystic fibrosis lung disease. J Immunol 181 (2008) 2753-2763
104. Greene C., Branagan P., and McElvaney N. Toll-like receptors as therapeutic targets in cystic fibrosis. Expert Opin Ther Targets 12 (2008) 1481-1495
105. Vaneker M., Joosten L., Heuks L., Snijdelaar D., Halbertsma F., Egmond J., et al. Low-tidal-volume mechanical ventilation induces a toll like receptor 4-dependent inflammatory response in healthy mice. Anesthesiology 109 (2008) 465-472